[HTML][HTML] Coordination modes of a Schiff base pentadentate derivative of 4-aminoantipyrine with cobalt (II), nickel (II) and copper (II) metal ions: synthesis, spectroscopic …
S Chandra, D Jain, AK Sharma, P Sharma - Molecules, 2009 - mdpi.com
Transition metal complexes of Co(II), Ni(II) and Cu(II) metal ions with general stoichiometry [M(L)X]X
and [M(L)SO 4 ], where M = Co(II), Ni(II) and Cu(II), L = 3,3’-thiodipropionic acid bis(4…
and [M(L)SO 4 ], where M = Co(II), Ni(II) and Cu(II), L = 3,3’-thiodipropionic acid bis(4…
Causes and histopathology of ascending aortic disease in children and young adults
D Jain, HC Dietz, GL Oswald, JJ Maleszewski… - Cardiovascular …, 2011 - Elsevier
BACKGROUND: Ascending aortic diseases (aneurysms, dissections, and stenosis) and
associated aortic valve disease are rare but important causes of morbidity and mortality in …
associated aortic valve disease are rare but important causes of morbidity and mortality in …
Cell blocks in cytopathology: an update
A Nambirajan, D Jain - Cytopathology, 2018 - Wiley Online Library
The cell block ( CB ) offers many advantages over other cytological preparations, particularly
for immunocytochemical and molecular testing. However, inconsistent cellularity remains …
for immunocytochemical and molecular testing. However, inconsistent cellularity remains …
[HTML][HTML] The 2021 WHO classification of lung tumors: impact of advances since 2015
…, E Brambilla, WA Cooper, S Dacic, D Jain… - Journal of Thoracic …, 2022 - Elsevier
The 2021 WHO Classification of Thoracic Tumours was published earlier this year, with
classification of lung tumors being one of the chapters. The principles remain those of using …
classification of lung tumors being one of the chapters. The principles remain those of using …
[HTML][HTML] A grading system for invasive pulmonary adenocarcinoma: a proposal from the International Association for the Study of Lung Cancer Pathology Committee
…, G Chen, TY Chou, JH Chung, S Dacic, D Jain… - Journal of Thoracic …, 2020 - Elsevier
Introduction A grading system for pulmonary adenocarcinoma has not been established. The
International Association for the Study of Lung Cancer pathology panel evaluated a set of …
International Association for the Study of Lung Cancer pathology panel evaluated a set of …
[HTML][HTML] The 2021 WHO classification of tumors of the thymus and mediastinum: what is new in thymic epithelial, germ cell, and mesenchymal tumors?
…, CA French, JL Hornick, H Inagaki, D Jain… - Journal of Thoracic …, 2022 - Elsevier
This overview of the fifth edition of the WHO classification of thymic epithelial tumors (including
thymomas, thymic carcinomas, and thymic neuroendocrine tumors [NETs]), mediastinal …
thymomas, thymic carcinomas, and thymic neuroendocrine tumors [NETs]), mediastinal …
[HTML][HTML] The promises and challenges of tumor mutation burden as an immunotherapy biomarker: a perspective from the International Association for the Study of …
…, WA Cooper, S Dacic, S Lantuejoul, D Jain… - Journal of Thoracic …, 2020 - Elsevier
Immune checkpoint inhibitor (ICI) therapies have revolutionized the management of patients
with NSCLC and have led to unprecedented improvements in response rates and survival …
with NSCLC and have led to unprecedented improvements in response rates and survival …
[HTML][HTML] IASLC multidisciplinary recommendations for pathologic assessment of lung cancer resection specimens after neoadjuvant therapy
…, FR Hirsch, H Horinouchi, K Kerr, M Kris, D Jain… - Journal of Thoracic …, 2020 - Elsevier
Currently, there is no established guidance on how to process and evaluate resected lung
cancer specimens after neoadjuvant therapy in the setting of clinical trials and clinical practice…
cancer specimens after neoadjuvant therapy in the setting of clinical trials and clinical practice…
[HTML][HTML] PD-L1 testing for lung cancer in 2019: perspective from the IASLC Pathology Committee
The recent development of immune checkpoint inhibitors (ICIs) has led to promising advances
in the treatment of patients with NSCLC and SCLC with advanced or metastatic disease. …
in the treatment of patients with NSCLC and SCLC with advanced or metastatic disease. …
Yes-associated protein 1 is widely expressed in human brain tumors and promotes glioblastoma growth
The hippo pathway and its downstream mediator yes-associated protein 1 (YAP1) regulate
mammalian organ size in part through modulating progenitor cell numbers. YAP1 has also …
mammalian organ size in part through modulating progenitor cell numbers. YAP1 has also …